According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -87,620.60%. At the end of 2021 the company had an Operating Margin of -29,448.99%.
Year | Operating Margin | Change |
---|---|---|
2021 | -29,448.99% | 11963.86% |
2020 | -244.11% | -733.43% |
2019 | 38.54% | -120.21% |
2018 | -190.71% | 21.57% |
2017 | -156.87% | -7.56% |
2016 | -169.71% | 4612.59% |
2015 | -3.60% | -99.18% |
2014 | -439.15% | -90.63% |
2013 | -4,686.14% | -53.7% |
2012 | -10,120.39% | 61.02% |
2011 | -6,285.29% | 203.02% |
2010 | -2,074.19% | 137.57% |
2009 | -873.07% | 191.26% |
2008 | -299.76% | 110.9% |
2007 | -142.13% | -290.09% |
2006 | 74.77% | 44.36% |
2005 | 51.79% | -167.38% |
2004 | -76.86% | -47.4% |
2003 | -146.12% | -18.22% |
2002 | -178.67% | 1151.14% |
2001 | -14.28% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 14.17% | -100.02% | ๐บ๐ธ USA |
Illumina ILMN | -94.58% | -99.89% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 37.68% | -100.04% | ๐บ๐ธ USA |
Ultragenyx RARE | -162.16% | -99.81% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | 17.06% | -100.02% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | -343.04% | -99.61% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | -10.86% | -99.99% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 4.83% | -100.01% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.